The Relationship Between HIV Infection and Atopic Dermatitis

Overview

Journal Curr Allergy Asthma Rep

Specialties Allergy & Immunology
Pulmonary Medicine

Date 2002 Jun 5

PMID 12044260

Citations 5

Authors

Donald Rudikoff

Affiliations

Soon will be listed here.

Abstract

Patients with HIV infection exhibit a wide range of skin pathology, including bacterial, fungal, and viral infections, skin tumors, inflammatory and eczematous eruptions, and drug rashes. HIV-infected adults commonly develop a condition that strongly resembles atopic dermatitis and is sometimes called "atopic-like dermatitis"; moreover, atopic dermatitis and other atopic disorders have been described as common manifestations of pediatric HIV infection. Conditions such as sinusitis, asthma, and hyper-IgE syndrome, and laboratory abnormalities, eg, elevated IgE levels, eosinophilia, and possible Th1-Th2 imbalances, suggest a predilection for atopic disorders in these patients. It is of interest to examine the immune perturbations intrinsic to HIV infection, and their possible role in triggering atopic dermatitis, and to consider whether other abnormalities, such as xerosis, bacterial or viral superantigens, or epidermal barrier disruption with altered presentation of cutaneous aeroallergens, might play a significant role.

Citing Articles

Successful treatment of severe and recurrent hand eczema with infection in human immunodeficiency virus patients: A case report.

Chen D, Liu W, Li Y SAGE Open Med Case Rep. 2024; 12:2050313X241260471.

PMID: 39071193 PMC: 11282564. DOI: 10.1177/2050313X241260471.

Dupilumab in HIV-positive patients: A case series report of 4 patients.

Alawadhi A, Karibayeva D, Gottlieb A JAAD Case Rep. 2020; 6(12):1356-1359.

PMID: 33304976 PMC: 7718127. DOI: 10.1016/j.jdcr.2020.09.023.

Antifungal and antioxidant activities of Coleonema album and C. pulchellum against skin diseases.

Fajinmi O, Gruz J, Tarkowski P, Kulkarni M, Finnie J, van Staden J Pharm Biol. 2017; 55(1):1249-1255.

PMID: 28262031 PMC: 6130550. DOI: 10.1080/13880209.2017.1296470.

Human Immunodeficiency Virus and Allergic Bronchopulmonary Aspergillosis: Case Report and Review of Literature.

Galiatsatos P, Melia M, Silhan L Open Forum Infect Dis. 2016; 3(2):ofw116.

PMID: 27419184 PMC: 4943533. DOI: 10.1093/ofid/ofw116.

Increased risk of asthma and atopic dermatitis in perinatally HIV-infected children and adolescents.

Siberry G, Leister E, Jacobson D, Foster S, Seage 3rd G, Lipshultz S Clin Immunol. 2011; 142(2):201-8.

PMID: 22094294 PMC: 3273595. DOI: 10.1016/j.clim.2011.10.005.

References

Horsmanheimo L, Harvima I, Jarvikallio A, Harvima R, Naukkarinen A, Horsmanheimo M . Mast cells are one major source of interleukin-4 in atopic dermatitis. Br J Dermatol. 1994; 131(3):348-53. DOI: 10.1111/j.1365-2133.1994.tb08522.x. View

Smith K, Barrett T, Neafie R, Tomaszewski M, Yeager J, Nelson A . Is CD30 (Ki-1) immunostaining in cutaneous eruptions useful as a marker of Th1 to Th2 cytokine switching and/or as a marker of advanced HIV-1 disease?. Br J Dermatol. 1998; 138(5):774-9. DOI: 10.1046/j.1365-2133.1998.02212.x. View

Koutsonikolis A, Nelson Jr R, Fernandez-Caldas E, Brigino E, Seleznick M, GOOD R . Serum total and specific IgE levels in children infected with human immunodeficiency virus. J Allergy Clin Immunol. 1996; 97(2):692-7. DOI: 10.1016/s0091-6749(96)70316-0. View

Paganelli R, Scala E, Mezzaroma I, Pinter E, DOffizi G, Fanales-Belasio E . Immunologic aspects of hyperimmunoglobulinemia E-like syndrome in patients with AIDS. J Allergy Clin Immunol. 1995; 95(5 Pt 1):995-1003. DOI: 10.1016/s0091-6749(95)70100-1. View

Frezzolini A, Paradisi M, Ruffelli M, Cadoni S, De Pita O . Soluble CD30 in pediatric patients with atopic dermatitis. Allergy. 1997; 52(1):106-9. DOI: 10.1111/j.1398-9995.1997.tb02554.x. View

Bengtsson A, Holm L, Back O, Fransson J, Scheynius A . Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD). Clin Exp Immunol. 1997; 109(3):533-7. PMC: 1904756. DOI: 10.1046/j.1365-2249.1997.4731373.x. View

Sample S, Chernoff D, Lenahan G, Serwonska M, Rangi S, Sherman J . Elevated serum concentrations of IgE antibodies to environmental antigens in HIV-seropositive male homosexuals. J Allergy Clin Immunol. 1990; 86(6 Pt 1):876-80. DOI: 10.1016/s0091-6749(05)80149-6. View

Marshall J, Chehimi J, Gri G, Kostman J, Montaner L, Trinchieri G . The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals. Blood. 1999; 94(3):1003-11. View

Del Prete G, Maggi E, Pizzolo G, Romagnani S . CD30, Th2 cytokines and HIV infection: a complex and fascinating link. Immunol Today. 1995; 16(2):76-80. DOI: 10.1016/0167-5699(95)80092-1. View

10.

de Jong E, Vieira P, Kalinski P, Schuitemaker J, Tanaka Y, Wierenga E . Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cell-polarizing signals. J Immunol. 2002; 168(4):1704-9. DOI: 10.4049/jimmunol.168.4.1704. View

11.

Yamamoto J, Adachi Y, Onoue Y, Kanegane H, Miyawaki T, Toyoda M . CD30 expression on circulating memory CD4+ T cells as a Th2-dominated situation in patients with atopic dermatitis. Allergy. 2000; 55(11):1011-8. DOI: 10.1034/j.1398-9995.2000.00685.x. View

12.

Maggi E, Mazzetti M, RAVINA A, Annunziato F, De Carli M, Piccinni M . Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. Science. 1994; 265(5169):244-8. DOI: 10.1126/science.8023142. View

13.

Skov L, Olsen J, Giorno R, Schlievert P, Baadsgaard O, Leung D . Application of Staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by a superantigen-mediated mechanism. J Allergy Clin Immunol. 2000; 105(4):820-6. DOI: 10.1067/mai.2000.105524. View

14.

Kondo H, Ichikawa Y, Imokawa G . Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur J Immunol. 1998; 28(3):769-79. DOI: 10.1002/(SICI)1521-4141(199803)28:03<769::AID-IMMU769>3.0.CO;2-H. View

15.

Nakazawa M, Sugi N, Kawaguchi H, Ishii N, Nakajima H, Minami M . Predominance of type 2 cytokine-producing CD4+ and CD8+ cells in patients with atopic dermatitis. J Allergy Clin Immunol. 1997; 99(5):673-82. DOI: 10.1016/s0091-6749(97)70030-7. View

16.

Ball L, Harper J . Atopic eczema in HIV-seropositive haemophiliacs. Lancet. 1987; 2(8559):627-8. DOI: 10.1016/s0140-6736(87)93016-9. View

17.

Brinchmann J, Gaudernack G, Thorsby E, Vartdal F . Staphylococcal exotoxin superantigens induce human immunodeficiency virus type 1 expression in naturally infected CD4+ T cells. J Virol. 1992; 66(10):5924-8. PMC: 241469. DOI: 10.1128/JVI.66.10.5924-5928.1992. View

18.

Paganelli R, Fanales-Belasio E, Scala E, Carmini D, Mezzaroma I, Pinter E . Serum eosinophil cationic protein (ECP) in human immunodeficiency virus (HIV) infection. J Allergy Clin Immunol. 1991; 88(3 Pt 1):416-8. DOI: 10.1016/0091-6749(91)90107-y. View

19.

Li Y, Li L, Wadley R, Reddel S, Qi J, Archis C . Mast cells/basophils in the peripheral blood of allergic individuals who are HIV-1 susceptible due to their surface expression of CD4 and the chemokine receptors CCR3, CCR5, and CXCR4. Blood. 2001; 97(11):3484-90. DOI: 10.1182/blood.v97.11.3484. View

20.

Bacot B, Paul M, Navarro M, Abramson S, Kline M, Hanson I . Objective measures of allergic disease in children with human immunodeficiency virus infection. J Allergy Clin Immunol. 1997; 100(5):707-11. DOI: 10.1016/s0091-6749(97)70177-5. View